{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:12:45Z","timestamp":1777403565179,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2003,5,28]],"date-time":"2003-05-28T00:00:00Z","timestamp":1054080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,28]],"date-time":"2003-05-28T00:00:00Z","timestamp":1054080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.1038\/sj.bmt.1704042","type":"journal-article","created":{"date-parts":[[2003,5,28]],"date-time":"2003-05-28T14:07:04Z","timestamp":1054130824000},"page":"967-972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation"],"prefix":"10.1038","volume":"31","author":[{"given":"S K","family":"Sohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J G","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N Y","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J S","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K B","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,28]]},"reference":[{"key":"BF1704042_CR1","first-page":"139a","volume":"92","author":"J Barrett","year":"1998","unstructured":"Barrett J, Bahceci E, Childs R et al. High CD34+ cell dose lowers relapse risk in standard and high-risk recipients of allogeneic bone marrow or peripheral blood stem cell transplants (PBSCT). Blood 1998; 92: 139a [abstract].","journal-title":"Blood"},{"key":"BF1704042_CR2","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V88.8.3223.bloodjournal8883223","volume":"88","author":"D Mavroudis","year":"1996","unstructured":"Mavroudis D, Read E, Cottler-Fox M et al. CD34+ cell dose predicts survival, post transplant mobidity and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88: 3223\u20133229.","journal-title":"Blood"},{"key":"BF1704042_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/sj.bmt.1702542","volume":"26","author":"S Singhal","year":"2000","unstructured":"Singhal S, Powles R, Treleaven J et al. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 \u00d7 106 CD34+ cells\/kg be considered the minimum threshold? Bone Marrow Transplant 2000; 26: 489\u2013496.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704042_CR4","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1182\/blood.V98.6.1695","volume":"98","author":"D Przepiorka","year":"2001","unstructured":"Przepiorka D, Anderlini P, Saliba R et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695\u20131700.","journal-title":"Blood"},{"key":"BF1704042_CR5","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1182\/blood.V99.8.2726","volume":"99","author":"H Bittencourt","year":"2002","unstructured":"Bittencourt H, Rocha V, Chevret S et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 99: 2726\u20132733.","journal-title":"Blood"},{"key":"BF1704042_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.1365-2141.2001.02983.x","volume":"115","author":"R Nakamura","year":"2001","unstructured":"Nakamura R, Bahceci E, Read EJ et al. Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back. Br J Haematol 2001; 115: 95\u2013104.","journal-title":"Br J Haematol"},{"key":"BF1704042_CR7","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1182\/blood.V98.8.2352","volume":"98","author":"A Urbano-Ispizua","year":"2001","unstructured":"Urbano-Ispizua A, Carreras E, Marin P et al. Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells. Blood 2001; 98: 2352\u20132357.","journal-title":"Blood"},{"key":"BF1704042_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.bmt.1703598","volume":"30","author":"SK Sohn","year":"2002","unstructured":"Sohn SK, Kim JG, Seo KW et al. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2002; 30: 81\u201386.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704042_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1056\/NEJM197504172921605","volume":"292","author":"E Thomas","year":"1975","unstructured":"Thomas E, Storb R, Clift RA et al. Bone-marrow transplantation. N Engl J Med 1975; 292: 832\u2013843.","journal-title":"N Engl J Med"},{"key":"BF1704042_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1046\/j.1365-2141.2001.03002.x","volume":"114","author":"S Brunet","year":"2001","unstructured":"Brunet S, Urbano-Ispizua A, Ojeda E et al. Spanish Group of Allogeneic-PBT. Spain. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies. Br J Haematol 2001; 114: 544\u2013550.","journal-title":"Br J Haematol"},{"key":"BF1704042_CR11","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","volume":"19","author":"C Cutler","year":"2001","unstructured":"Cutler C, Giri S, Jeyapalan S et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685\u20133691.","journal-title":"J Clin Oncol"},{"key":"BF1704042_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1046\/j.1365-2141.2000.01838.x","volume":"108","author":"E Bahceci","year":"2000","unstructured":"Bahceci E, Read EJ, Leitman S et al. CD34+ cell dose predicts relapse and survival after T-cell depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies. Br J Haematol 2000; 108: 408\u2013414.","journal-title":"Br J Haematol"},{"key":"BF1704042_CR13","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1182\/blood.V98.12.3221","volume":"98","author":"JM Zaucha","year":"2001","unstructured":"Zaucha JM, Gooley T, Bensinger WI et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221\u20133227.","journal-title":"Blood"},{"key":"BF1704042_CR14","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","volume":"94","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Smith TL, Folloder J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465\u20131470.","journal-title":"Blood"},{"key":"BF1704042_CR15","first-page":"747","volume":"16","author":"H Hagglund","year":"1995","unstructured":"Hagglund H, Bostrom L, Remberger M et al. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients. Bone Marrow Transplant 1995; 16: 747\u2013753.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704042_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bmt.1702852","volume":"27","author":"R Morariu-Zamfir","year":"2001","unstructured":"Morariu-Zamfir R, Rocha V, Devergie A et al. Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Bone Marrow Transplant 2001; 27: 575\u2013580.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704042_CR17","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V85.6.1666.bloodjournal8561666","volume":"85","author":"N Schmitz","year":"1995","unstructured":"Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666\u20131672.","journal-title":"Blood"},{"key":"BF1704042_CR18","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V85.6.1655.bloodjournal8561655","volume":"85","author":"WI Bensinger","year":"1995","unstructured":"Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655\u20131658.","journal-title":"Blood"},{"key":"BF1704042_CR19","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","volume":"85","author":"M Korbling","year":"1995","unstructured":"Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659\u20131965.","journal-title":"Blood"},{"key":"BF1704042_CR20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF1704042_CR21","first-page":"556a","volume":"96","author":"SJ Lee","year":"2000","unstructured":"Lee SJ, Klein JP, Barrett AJ et al. Chronic graft-vs-host disease (cGVHD) severity score: effects on leukemia-free survival. Blood 2000; 96: 556a [abstract].","journal-title":"Blood"},{"key":"BF1704042_CR22","first-page":"413a","volume":"98","author":"O Ringden","year":"2001","unstructured":"Ringden O, Barrett AJ, Zhang M et al. A high CD34+ cell dose is associated with improved leukemia-free survival in recipients of HLA-identical bone marrow or peripheral blood stem cells [abstract]. Blood 2001; 98: 413a.","journal-title":"Blood"},{"key":"BF1704042_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cncr.10165","volume":"94","author":"SK Sohn","year":"2002","unstructured":"Sohn SK, Jung JT, Kim DH et al. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies. Cancer 2002; 94: 18\u201324.","journal-title":"Cancer"},{"key":"BF1704042_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1182\/blood.V98.6.1739","volume":"98","author":"M Remberger","year":"2001","unstructured":"Remberger M, Ringden O, Blau IW et al. No difference in graft-versus-host disease relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 2001; 98: 1739\u20131745.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704042","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:22:38Z","timestamp":1648077758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,28]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,6,1]]}},"alternative-id":["BF1704042"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704042","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,28]]},"assertion":[{"value":"3 September 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}